Prescription Pharmaceuticals Market – Global Industry Analysis and Forecast (2023-2029)


Global Prescription Pharmaceuticals Market is expected to grow at a CAGR of 8.85% during the forecast period and the market size is expected to reach nearly US$ 2133.66 Bn by 2029.

The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report

Key Highlights:

Market analysis and forecast, in terms of value.
Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the market.
Market segmentation on the basic product, service, and geography (country-wise) has been provided.
The Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of the study.
Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the market are also profiled.

For company profiles, 2022 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered.

Prescription Pharmaceuticals Market Research Methodology:

The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for market.

Prescription Pharmaceuticals Market Key Target Audience:

Research and consulting companies
Global Prescription Pharmaceuticals market Investors
Organization associated with Research and Development (R&D)
Global Prescription Pharmaceuticals marketing players
Academic medical centers and universities

Scope of the Prescription Pharmaceuticals Market report: Inquire before buying

The research report categorizes the Global market based on Therapeutic Segments, Formulations, and geography. Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global market with key developments in companies and market trends





Global Prescription Pharmaceuticals Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 1178.49 Bn.




Forecast Period 2023 to 2029 CAGR:
8.85%
Market Size in 2029:
US $ 2133.66 Bn.




 Segments Covered:
by Therapeutic Segments
Cardiovascular Disorders
Oncology
Inflammatory Conditions
Infectious Diseases
Metabolic Disorders
Respiratory Disorders
Other Therapeutic Segments




by Formulations
Capsules
Tablets
Inhalants and Liquids
Parenterals
Topicals






Prescription Pharmaceuticals Market, by Region:

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key players in the Global Prescription Pharmaceuticals market :

1. Bayer AG
2. AstraZeneca
3. Gilead Sciences
4. Johnson & Johnson
5. GlaxoSmithKline
6. Novartis A.G.
7. Merck & Co.
8. Pfizer
9. Sanofi S.A
10. F. Hoffmann-La Roche
11. Eli Lilly and Company
12. Lonza
13. AbbVie, Inc.
14. Celgene Corporation
15. Mallinckrodt Pharmaceuticals

Frequently Asked Questions:

1. Which region has the largest share in Global Prescription Pharmaceuticals Market?
Ans: Asia Pacific region holds the highest share in 2022.

2. What is the growth rate of Global Prescription Pharmaceuticals Market?
Ans: The Global Prescription Pharmaceuticals Market is growing at a CAGR of 8.85% during forecasting period 2023-2029.

3. What is scope of the Global Prescription Pharmaceuticals market report?
Ans: Global Prescription Pharmaceuticals Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Prescription Pharmaceuticals market?
Ans: The important key players in the Global Prescription Pharmaceuticals Market are – Bayer AG, AstraZeneca, Gilead Sciences, Johnson & Johnson, GlaxoSmithKline, Novartis A.G., Merck & Co., Pfizer, Sanofi S.A, F. Hoffmann-La Roche, Eli Lilly and Company, Lonza, AbbVie, Inc., Celgene Corporation, and Mallinckrodt Pharmaceuticals

5. What is the study period of this market?
Ans: The Global Prescription Pharmaceuticals Market is studied from 2022 to 2029. 





Global Prescription Pharmaceuticals Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Prescription Pharmaceuticals Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
4.8. Patent Registration

5. Supply Side and Demand Side Indicators

6. Global Prescription Pharmaceuticals Market Analysis and Forecast
6.1. Global Prescription Pharmaceuticals Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Prescription Pharmaceuticals Market Analysis and Forecast, by Therapeutic Segments
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Prescription Pharmaceuticals Market Value Share Analysis, by Therapeutic Segments
7.4. Global Prescription Pharmaceuticals Market Size (US$ Bn) Forecast, by Therapeutic Segments
7.5. Global Prescription Pharmaceuticals Market Analysis, by Therapeutic Segments
7.6. Global Prescription Pharmaceuticals Market Attractiveness Analysis, by Therapeutic Segments

8. Global Prescription Pharmaceuticals Market Analysis and Forecast, by Formulations
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Prescription Pharmaceuticals Market Value Share Analysis, by Formulations
8.4. Global Prescription Pharmaceuticals Market Size (US$ Bn) Forecast, by Formulations
8.5. Global Prescription Pharmaceuticals Market Analysis, by Formulations
8.6. Global Prescription Pharmaceuticals Market Attractiveness Analysis, by Formulations

9. Global Prescription Pharmaceuticals Market Analysis, by Region
9.1. Global Prescription Pharmaceuticals Market Value Share Analysis, by Region
9.2. Global Prescription Pharmaceuticals Market Size (US$ Bn) Forecast, by Region
9.3. Global Prescription Pharmaceuticals Market Attractiveness Analysis, by Region

10. North America Prescription Pharmaceuticals Market Analysis
10.1. Key Findings
10.2. North America Prescription Pharmaceuticals Market Overview
10.3. North America Prescription Pharmaceuticals Market Value Share Analysis, by Therapeutic Segments
10.4. North America Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
10.4.1. Cardiovascular Disorders
10.4.2. Oncology
10.4.3. Inflammatory Conditions
10.4.4. Infectious Diseases
10.4.5. Metabolic Disorders
10.4.6. Respiratory Disorders
10.4.7. Others
10.5. North America Prescription Pharmaceuticals Market Value Share Analysis, by Formulations
10.6. North America Prescription Pharmaceuticals Market Forecast, by Formulations
10.6.1. Capsules
10.6.2. Tablets
10.6.3. Inhalants and Liquids
10.6.4. Parenterals
10.6.5. Topicals
10.7. North America Prescription Pharmaceuticals Market Value Share Analysis, by Country
10.8. North America Prescription Pharmaceuticals Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.9. North America Prescription Pharmaceuticals Market Analysis, by Country
10.10. U.S. Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
10.10.1. Cardiovascular Disorders
10.10.2. Oncology
10.10.3. Inflammatory Conditions
10.10.4. Infectious Diseases
10.10.5. Metabolic Disorders
10.10.6. Respiratory Disorders
10.10.7. Others
10.11. U.S. Prescription Pharmaceuticals Market Forecast, by Formulations
10.11.1. Capsules
10.11.2. Tablets
10.11.3. Inhalants and Liquids
10.11.4. Parenterals
10.11.5. Topicals
10.12. Canada Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
10.12.1. Cardiovascular Disorders
10.12.2. Oncology
10.12.3. Inflammatory Conditions
10.12.4. Infectious Diseases
10.12.5. Metabolic Disorders
10.12.6. Respiratory Disorders
10.12.7. Others
10.13. Canada Prescription Pharmaceuticals Market Forecast, by Formulations
10.13.1. Capsules
10.13.2. Tablets
10.13.3. Inhalants and Liquids
10.13.4. Parenterals
10.13.5. Topicals
10.14. North America Prescription Pharmaceuticals Market Attractiveness Analysis
10.14.1. By Therapeutic Segments
10.14.2. by Formulations
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Development

11. Europe Prescription Pharmaceuticals Market Analysis
11.1. Key Findings
11.2. Europe Prescription Pharmaceuticals Market Overview
11.3. Europe Prescription Pharmaceuticals Market Value Share Analysis, by Therapeutic Segments
11.4. Europe Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
11.4.1. Cardiovascular Disorders
11.4.2. Oncology
11.4.3. Inflammatory Conditions
11.4.4. Infectious Diseases
11.4.5. Metabolic Disorders
11.4.6. Respiratory Disorders
11.4.7. Others
11.5. Europe Prescription Pharmaceuticals Market Value Share Analysis, by Formulations
11.6. Europe Prescription Pharmaceuticals Market Forecast, by Formulations
11.6.1. Capsules
11.6.2. Tablets
11.6.3. Inhalants and Liquids
11.6.4. Parenterals
11.6.5. Topicals
11.6.6. Europe Prescription Pharmaceuticals Market Value Share Analysis, by Country
11.7. Europe Prescription Pharmaceuticals Market Forecast, by Country
11.7.1. Germany
11.7.2. U.K.
11.7.3. France
11.7.4. Italy
11.7.5. Spain
11.7.6. Rest of Europe
11.8. Europe Prescription Pharmaceuticals Market Analysis, by Country
11.9. Germany Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
11.9.1. Cardiovascular Disorders
11.9.2. Oncology
11.9.3. Inflammatory Conditions
11.9.4. Infectious Diseases
11.9.5. Metabolic Disorders
11.9.6. Respiratory Disorders
11.9.7. Others
11.10. Germany Prescription Pharmaceuticals Market Forecast, by Formulations
11.10.1. Capsules
11.10.2. Tablets
11.10.3. Inhalants and Liquids
11.10.4. Parenterals
11.10.5. Topicals
11.11. U.K. Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
11.11.1. Cardiovascular Disorders
11.11.2. Oncology
11.11.3. Inflammatory Conditions
11.11.4. Infectious Diseases
11.11.5. Metabolic Disorders
11.11.6. Respiratory Disorders
11.11.7. Others
11.12. U.K. Prescription Pharmaceuticals Market Forecast, by Formulations
11.12.1. Capsules
11.12.2. Tablets
11.12.3. Inhalants and Liquids
11.12.4. Parenterals
11.12.5. Topicals
11.13. France Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
11.13.1. Cardiovascular Disorders
11.13.2. Oncology
11.13.3. Inflammatory Conditions
11.13.4. Infectious Diseases
11.13.5. Metabolic Disorders
11.13.6. Respiratory Disorders
11.13.7. Others
11.14. France Prescription Pharmaceuticals Market Forecast, by Formulations
11.14.1. Capsules
11.14.2. Tablets
11.14.3. Inhalants and Liquids
11.14.4. Parenterals
11.14.5. Topicals
11.15. Italy Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
11.15.1. Cardiovascular Disorders
11.15.2. Oncology
11.15.3. Inflammatory Conditions
11.15.4. Infectious Diseases
11.15.5. Metabolic Disorders
11.15.6. Respiratory Disorders
11.15.7. Others
11.16. Italy Prescription Pharmaceuticals Market Forecast, by Formulations
11.16.1. Capsules
11.16.2. Tablets
11.16.3. Inhalants and Liquids
11.16.4. Parenterals
11.16.5. Topicals
11.17. Spain Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
11.17.1. Cardiovascular Disorders
11.17.2. Oncology
11.17.3. Inflammatory Conditions
11.17.4. Infectious Diseases
11.17.5. Metabolic Disorders
11.17.6. Respiratory Disorders
11.17.7. Others
11.18. Spain Prescription Pharmaceuticals Market Forecast, by Formulations
11.18.1. Capsules
11.18.2. Tablets
11.18.3. Inhalants and Liquids
11.18.4. Parenterals
11.18.5. Topicals
11.19. Rest of Europe Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
11.19.1. Cardiovascular Disorders
11.19.2. Oncology
11.19.3. Inflammatory Conditions
11.19.4. Infectious Diseases
11.19.5. Metabolic Disorders
11.19.6. Respiratory Disorders
11.19.7. Others
11.20. Rest of Europe Prescription Pharmaceuticals Market Forecast, by Formulations
11.20.1. Capsules
11.20.2. Tablets
11.20.3. Inhalants and Liquids
11.20.4. Parenterals
11.20.5. Topicals
11.21. Europe Prescription Pharmaceuticals Market Attractiveness Analysis
11.21.1. By Therapeutic Segments
11.21.2. by Formulations
11.22. PEST Analysis
11.23. Key Trend
11.24. Key Development

12. Asia Pacific Prescription Pharmaceuticals Market Analysis
12.1. Key Findings
12.2. Asia Pacific Prescription Pharmaceuticals Market Overview
12.3. Asia Pacific Prescription Pharmaceuticals Market Value Share Analysis, by Therapeutic Segments
12.4. Asia Pacific Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
12.4.1. Cardiovascular Disorders
12.4.2. Oncology
12.4.3. Inflammatory Conditions
12.4.4. Infectious Diseases
12.4.5. Metabolic Disorders
12.4.6. Respiratory Disorders
12.4.7. Others
12.5. Asia Pacific Prescription Pharmaceuticals Market Value Share Analysis, by Formulations
12.6. Asia Pacific Prescription Pharmaceuticals Market Forecast, by Formulations
12.6.1. Capsules
12.6.2. Tablets
12.6.3. Inhalants and Liquids
12.6.4. Parenterals
12.6.5. Topicals
12.7. Asia Pacific Prescription Pharmaceuticals Market Value Share Analysis, by Country
12.8. Asia Pacific Prescription Pharmaceuticals Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific Prescription Pharmaceuticals Market Analysis, by Country
12.10. China Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
12.10.1. Cardiovascular Disorders
12.10.2. Oncology
12.10.3. Inflammatory Conditions
12.10.4. Infectious Diseases
12.10.5. Metabolic Disorders
12.10.6. Respiratory Disorders
12.10.7. Others
12.11. China Prescription Pharmaceuticals Market Forecast, by Formulations
12.11.1. Capsules
12.11.2. Tablets
12.11.3. Inhalants and Liquids
12.11.4. Parenterals
12.11.5. Topicals
12.12. India Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
12.12.1. Cardiovascular Disorders
12.12.2. Oncology
12.12.3. Inflammatory Conditions
12.12.4. Infectious Diseases
12.12.5. Metabolic Disorders
12.12.6. Respiratory Disorders
12.12.7. Others
12.13. India Prescription Pharmaceuticals Market Forecast, by Formulations
12.13.1. Capsules
12.13.2. Tablets
12.13.3. Inhalants and Liquids
12.13.4. Parenterals
12.13.5. Topicals
12.14. Japan Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
12.14.1. Cardiovascular Disorders
12.14.2. Oncology
12.14.3. Inflammatory Conditions
12.14.4. Infectious Diseases
12.14.5. Metabolic Disorders
12.14.6. Respiratory Disorders
12.14.7. Others
12.15. Japan Prescription Pharmaceuticals Market Forecast, by Formulations
12.15.1. Capsules
12.15.2. Tablets
12.15.3. Inhalants and Liquids
12.15.4. Parenterals
12.15.5. Topicals
12.16. ASEAN Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
12.16.1. Cardiovascular Disorders
12.16.2. Oncology
12.16.3. Inflammatory Conditions
12.16.4. Infectious Diseases
12.16.5. Metabolic Disorders
12.16.6. Respiratory Disorders
12.16.7. Others
12.17. ASEAN Prescription Pharmaceuticals Market Forecast, by Formulations
12.17.1. Capsules
12.17.2. Tablets
12.17.3. Inhalants and Liquids
12.17.4. Parenterals
12.17.5. Topicals
12.18. Rest of Asia Pacific Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
12.18.1. Cardiovascular Disorders
12.18.2. Oncology
12.18.3. Inflammatory Conditions
12.18.4. Infectious Diseases
12.18.5. Metabolic Disorders
12.18.6. Respiratory Disorders
12.18.7. Others
12.19. Rest of Asia Pacific Prescription Pharmaceuticals Market Forecast, by Formulations
12.19.1. Capsules
12.19.2. Tablets
12.19.3. Inhalants and Liquids
12.19.4. Parenterals
12.19.5. Topicals
12.20. Asia Pacific Prescription Pharmaceuticals Market Attractiveness Analysis
12.20.1. By Therapeutic Segments
12.20.2. by Formulations
12.21. PEST Analysis
12.22. Key Trend
12.23. Key Development

13. Middle East & Africa Prescription Pharmaceuticals Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Prescription Pharmaceuticals Market Overview
13.3. Middle East & Africa Prescription Pharmaceuticals Market Value Share Analysis, by Therapeutic Segments
13.4. Middle East & Africa Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
13.4.1. Cardiovascular Disorders
13.4.2. Oncology
13.4.3. Inflammatory Conditions
13.4.4. Infectious Diseases
13.4.5. Metabolic Disorders
13.4.6. Respiratory Disorders
13.4.7. Others
13.5. Middle East & Africa Prescription Pharmaceuticals Market Value Share Analysis, by Formulations
13.6. Middle East & Africa Prescription Pharmaceuticals Market Forecast, by Formulations
13.6.1. Capsules
13.6.2. Tablets
13.6.3. Inhalants and Liquids
13.6.4. Parenterals
13.6.5. Topicals
13.7. Middle East & Africa Prescription Pharmaceuticals Market Value Share Analysis, by Country
13.8. Middle East & Africa Prescription Pharmaceuticals Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Prescription Pharmaceuticals Market Analysis, by Country
13.10. GCC Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
13.10.1. Cardiovascular Disorders
13.10.2. Oncology
13.10.3. Inflammatory Conditions
13.10.4. Infectious Diseases
13.10.5. Metabolic Disorders
13.10.6. Respiratory Disorders
13.10.7. Others
13.11. GCC Prescription Pharmaceuticals Market Forecast, by Formulations
13.11.1. Capsules
13.11.2. Tablets
13.11.3. Inhalants and Liquids
13.11.4. Parenterals
13.11.5. Topicals
13.12. South Africa Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
13.12.1. Cardiovascular Disorders
13.12.2. Oncology
13.12.3. Inflammatory Conditions
13.12.4. Infectious Diseases
13.12.5. Metabolic Disorders
13.12.6. Respiratory Disorders
13.12.7. Others
13.13. South Africa Prescription Pharmaceuticals Market Forecast, by Formulations
13.13.1. Capsules
13.13.2. Tablets
13.13.3. Inhalants and Liquids
13.13.4. Parenterals
13.13.5. Topicals
13.14. Rest of Middle East & Africa Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
13.14.1. Cardiovascular Disorders
13.14.2. Oncology
13.14.3. Inflammatory Conditions
13.14.4. Infectious Diseases
13.14.5. Metabolic Disorders
13.14.6. Respiratory Disorders
13.14.7. Others
13.15. Rest of Middle East & Africa Prescription Pharmaceuticals Market Forecast, by Formulations
13.15.1. Capsules
13.15.2. Tablets
13.15.3. Inhalants and Liquids
13.15.4. Parenterals
13.15.5. Topicals
13.16. Middle East & Africa Prescription Pharmaceuticals Market Attractiveness Analysis
13.16.1. By Therapeutic Segments
13.16.2. by Formulations
13.17. PEST Analysis
13.18. Key Trend
13.19. Key Development

14. South America Prescription Pharmaceuticals Market Analysis
14.1. Key Findings
14.2. South America Prescription Pharmaceuticals Market Overview
14.3. South America Prescription Pharmaceuticals Market Value Share Analysis, by Therapeutic Segments
14.4. South America Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
14.4.1. Cardiovascular Disorders
14.4.2. Oncology
14.4.3. Inflammatory Conditions
14.4.4. Infectious Diseases
14.4.5. Metabolic Disorders
14.4.6. Respiratory Disorders
14.4.7. Others
14.5. Others South America Prescription Pharmaceuticals Market Value Share Analysis, by Formulations
14.6. South America Prescription Pharmaceuticals Market Forecast, by Formulations
14.6.1. Capsules
14.6.2. Tablets
14.6.3. Inhalants and Liquids
14.6.4. Parenterals
14.6.5. Topicals
14.7. South America Prescription Pharmaceuticals Market Value Share Analysis, by Country
14.8. South America Prescription Pharmaceuticals Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. Brazil Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
14.9.1. Cardiovascular Disorders
14.9.2. Oncology
14.9.3. Inflammatory Conditions
14.9.4. Infectious Diseases
14.9.5. Metabolic Disorders
14.9.6. Respiratory Disorders
14.9.7. Others
14.10. Brazil Prescription Pharmaceuticals Market Forecast, by Formulations
14.10.1. Capsules
14.10.2. Tablets
14.10.3. Inhalants and Liquids
14.10.4. Parenterals
14.10.5. Topicals
14.11. Mexico Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
14.11.1. Cardiovascular Disorders
14.11.2. Oncology
14.11.3. Inflammatory Conditions
14.11.4. Infectious Diseases
14.11.5. Metabolic Disorders
14.11.6. Respiratory Disorders
14.11.7. Others
14.12. Mexico Prescription Pharmaceuticals Market Forecast, by Formulations
14.12.1. Capsules
14.12.2. Tablets
14.12.3. Inhalants and Liquids
14.12.4. Parenterals
14.12.5. Topicals
14.13. Rest of South America Prescription Pharmaceuticals Market Forecast, by Therapeutic Segments
14.13.1. Cardiovascular Disorders
14.13.2. Oncology
14.13.3. Inflammatory Conditions
14.13.4. Infectious Diseases
14.13.5. Metabolic Disorders
14.13.6. Respiratory Disorders
14.13.7. Others
14.14. Rest of South America Prescription Pharmaceuticals Market Forecast, by Formulations
14.14.1. Capsules
14.14.2. Tablets
14.14.3. Inhalants and Liquids
14.14.4. Parenterals
14.14.5. Topicals
14.15. South America Prescription Pharmaceuticals Market Attractiveness Analysis
14.15.1. By Therapeutic Segments
14.15.2. by Formulations
14.16. PEST Analysis
14.17. Key Trend
14.18. Key Development

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
15.2.2. New Formulations Launches and Formulations Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Applications
15.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
15.3. Company Profiles: Key Players
15.3.1. Bayer AG
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Formulations Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Manufacturing Footprint
15.3.2. AstraZeneca
15.3.3. Gilead Sciences
15.3.4. Johnson & Johnson
15.3.5. GlaxoSmithKline
15.3.6. Novartis A.G.
15.3.7. Merck & Co.
15.3.8. Pfizer
15.3.9. Sanofi S.A
15.3.10. F. Hoffmann-La Roche
15.3.11. Eli Lilly and Company
15.3.12. Lonza
15.3.13. AbbVie, Inc.
15.3.14. Celgene Corporation
15.3.15. Mallinckrodt Pharmaceuticals

16. Primary Key Insights
  • INQUIRE BEFORE BUYING